Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Healthcare
Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Analyst Forecast
View:
Post by sollmg on Feb 24, 2022 3:11pm

Analyst Forecast

Analyst Forecast - USD

The average price target for VMD is $10.60, which is 176.76% higher than the current price. The consensus rating is "Buy".

$10.60
176.76%
Buy
8

https://stockanalysis.com/stocks/vmd/statistics/
Comment by JackLambert on Feb 25, 2022 6:51am
Indeed.   I too take comfort from this.  After a shocking reversal from the Royal last year when their analyst changed we have settled in to a wait and see period.   My DCF says $11.50 now.   Still disappointing given where we were in 2020 but far from hysterical.  I would however like to see the end of the Maximus situation - far too much noise for a lousy $9 million ...more  
Viemed Healthcare Inc